BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 7634391)

  • 1. Cross-platform toxicogenomics for the prediction of non-genotoxic hepatocarcinogenesis in rat.
    Römer M; Eichner J; Metzger U; Templin MF; Plummer S; Ellinger-Ziegelbauer H; Zell A
    PLoS One; 2014; 9(5):e97640. PubMed ID: 24830643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings?
    Smolle E; Zöhrer E; Bettermann K; Haybaeck J
    Hepat Mon; 2012 Oct; 12(10 HCC):e7879. PubMed ID: 23233866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental mouse models for hepatocellular carcinoma research.
    Heindryckx F; Colle I; Van Vlierberghe H
    Int J Exp Pathol; 2009 Aug; 90(4):367-86. PubMed ID: 19659896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the p50 subunit of NF-kappaB in vitamin E-induced changes in mice treated with the peroxisome proliferator, ciprofibrate.
    Calfee-Mason KG; Lee EY; Spear BT; Glauert HP
    Food Chem Toxicol; 2008 Jun; 46(6):2062-73. PubMed ID: 18336980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.
    Rusyn I; Peters JM; Cunningham ML
    Crit Rev Toxicol; 2006 May; 36(5):459-79. PubMed ID: 16954067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease.
    Boitier E; Gautier JC; Roberts R
    Comp Hepatol; 2003 Jan; 2(1):3. PubMed ID: 12622871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functions of cytokines and their uses in toxicology.
    Foster JR
    Int J Exp Pathol; 2001 Jun; 82(3):171-92. PubMed ID: 11488991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology of senescent liver peroxisomes: role in hepatocellular aging and disease.
    Youssef J; Badr M
    Environ Health Perspect; 1999 Oct; 107(10):791-7. PubMed ID: 10504144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anomalous nonidentity between Salmonella genotoxicants and rodent carcinogens: nongenotoxic carcinogens and genotoxic noncarcinogens.
    Yoshikawa K
    Environ Health Perspect; 1996 Jan; 104(1):40-6. PubMed ID: 8834860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-genotoxic hepatocarcinogenesis: suppression of apoptosis by peroxisome proliferators.
    Roberts RA
    Ann N Y Acad Sci; 1996 Dec; 804():588-611. PubMed ID: 8993575
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of primary cultures of adult rat hepatocytes to study induction of enzymes and DNA synthesis: effect of nafenopin and electroporation.
    Muakkassah-Kelly SF; Bieri F; Waechter F; Bentley P; Stäubli W
    Experientia; 1988 Oct; 44(10):823-7. PubMed ID: 3053229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations.
    Roberts RA; Soames AR; Gill JH; James NH; Wheeldon EB
    Carcinogenesis; 1995 Aug; 16(8):1693-8. PubMed ID: 7634391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
    James NH; Roberts RA
    Carcinogenesis; 1994 Dec; 15(12):2687-94. PubMed ID: 8001222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rodent non-genotoxic hepatocarcinogen nafenopin suppresses apoptosis preferentially in non-cycling hepatocytes but also elevates CDK4, a cell cycle progression factor.
    Gill JH; Brickell P; Dive C; Roberts RA
    Carcinogenesis; 1998 Oct; 19(10):1743-7. PubMed ID: 9806153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
    James NH; Roberts RA
    Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.